- Christensen R, et al. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a metaanalysis of randomized controlled trials. Osteoarthritis Cartilage. 2008;16:399-408.
- Maheu E, et al. Symptomatic efficacy of avocado/ soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum 1998;41:81-91.
- Blotman F, et al. Efficacy and safety of avocado/ soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev Rhum (Engl Ed) 1997;64:825-34.
- Maheu E, et al. Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure moadification in hip osteoarthritis: the ERADIAS study. Ann Rheum Dis. 2014;73:376-84.
- Appelboom T, Schuermans J, Verbruggen G, et al. Symptoms modifying - effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo controlled study. Scand J Rheumatol 2001; 30:242–7.
- Henrotin YE, Sanchez C, Deberg MA, et al. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by humanosteoarthritic chondrocytes. J Rheumatol 2003; 30:1825–34.
- Altinel L, et al. Treatment with unsaponifiable extracts of avocado and soybean increases TGF-beta1 and TGF-beta2 levels in canine joint fluid. Tohoku J Exp Med 2007;211:181-6.
- Mc Alindon TE et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Catilage 2014;22:363-88.
- Jordan KM et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145 55.
- Rillo O. et al. PANLAR Consensus Recommendations for the Management in Osteoarthritis of Hand, Hip, and Knee. J Clin Rheumatol. 2016 Oct;22(7):345-54.
- IQVIA, MIDAS Data – year 2017 (Retail sales withoutChina and Sri Lanka).
- Инструкция по применению лекарственного средства «Пиаскледин».
Інформація, яка міститься на цьому сайті, призначена винятково для користувачів на території
України.
Реклама лікарського засобу. Перед застосуванням обов’язково ознайомтесь з інструкцією та
проконсультуйтесь з лікарем.